The stepmother of the late “Friends” star Matthew Perry delivered an emotional plea for the harshest possible punishment against the woman dubbed the “Ketamine Queen,” describing the family’s pain as “irreversible” in a victim impact statement filed just before the drug dealer’s sentencing Wednesday.
AFP
Debbie Perry, married to the actor’s father John Bennett Perry, urged a federal judge in Los Angeles to impose the maximum prison term on Jasveen Sangha, the 42-year-old North Hollywood woman who admitted supplying the ketamine that led to Perry’s fatal overdose in October 2023. Sangha could face more than 60 years behind bars after pleading guilty to five federal charges, including one count of distribution of ketamine resulting in death or serious bodily injury.
“Please give this heartless woman the maximum prison sentence so she won’t be able to hurt other families like ours,” Debbie Perry wrote in the statement submitted to the U.S. District Court for the Central District of California on April 7. She described the family’s ongoing grief, saying there is “no joy to be found, no light in the window” and that the loss “comes through our day everyday.”
The statement, obtained by multiple news outlets, highlighted the profound and lasting damage caused by Sangha’s actions. “The pain you’ve caused to hundreds maybe thousands is irreversible,” Debbie Perry continued. “You caused this. You who has talent for business, enough to make money, chose the one way that hurts people.”
Sangha, known among clients as the “Ketamine Queen,” ran what prosecutors described as an elaborate drug operation catering to high-end customers. She admitted to working with another dealer to provide dozens of vials of ketamine to Perry, including the dose that contributed to his drowning death at age 54 in the hot tub of his Pacific Palisades home. Perry, who had long struggled with addiction and documented his battles in his 2022 memoir, was found unresponsive on Oct. 28, 2023.
Advertisement
The case has drawn intense public attention, shining a spotlight on the dangers of ketamine misuse, especially when obtained illegally outside clinical settings. Ketamine, a dissociative anesthetic sometimes used legitimately for depression treatment under medical supervision, can cause severe respiratory depression and loss of consciousness when abused in high doses.
Sangha pleaded guilty in September 2025 to maintaining a drug-involved premises, three counts of distribution of ketamine and the count tied to Perry’s death. Her sentencing hearing was scheduled for Wednesday morning in downtown Los Angeles federal court. Prosecutors have recommended at least 15 years in prison, while her defense has reportedly sought time served or a lighter term.
She becomes the third of five defendants to face sentencing in the high-profile case. On Tuesday, Dr. Salvador Plasencia, one of the physicians involved, was sentenced to 30 months in prison for his role in supplying ketamine to Perry. Another defendant, Perry’s live-in assistant Kenneth Iwamasa, previously pleaded guilty to conspiracy to distribute ketamine and faces his own sentencing.
Prosecutors portrayed Sangha as a central figure in a network that profited from providing powerful drugs to vulnerable individuals. Court filings alleged she operated with sophistication, using multiple phones and catering to wealthy clients seeking ketamine for recreational or self-medication purposes. The government emphasized that her actions directly contributed to Perry’s death, even as the actor was attempting to manage his addiction.
Advertisement
Debbie Perry’s statement marked the family’s most public expression of grief and anger in recent months. While Perry’s biological mother, Suzanne Morrison, and other relatives have spoken sparingly, Debbie Perry’s words underscored the collective family trauma three years after the loss. The family has largely avoided the spotlight, focusing instead on honoring Matthew Perry’s legacy through his foundation and advocacy for addiction recovery.
Matthew Perry rose to global fame as the sarcastic Chandler Bing on the NBC sitcom “Friends,” which aired from 1994 to 2004. He earned an Emmy nomination for the role and later starred in films and other television projects. Behind the success, however, Perry battled severe substance abuse issues for decades, including prescription opioids and alcohol. In his memoir “Friends, Lovers, and the Big Terrible Thing,” he detailed his struggles with sobriety and the physical toll of addiction.
His death at 54 shocked fans worldwide and prompted renewed discussions about celebrity addiction, the opioid crisis and the emerging risks of ketamine. The actor had reportedly been receiving ketamine infusions legally for depression in the period leading up to his death, but the fatal dose came from illegal sources obtained through the charged defendants.
The case has unfolded slowly through the federal court system. Arrests began in August 2024, with Sangha taken into custody and held without bail. Her plea deal in late 2025 resolved the charges against her without a trial, allowing the focus to shift to sentencing.
Advertisement
Legal experts note that while the maximum statutory penalty exceeds 60 years, actual sentences in such cases often fall significantly lower based on guidelines, cooperation and other factors. Prosecutors’ push for 15 years reflects the gravity of the conduct while acknowledging typical federal sentencing ranges for similar offenses.
Sangha’s operation allegedly extended beyond Perry, with authorities claiming she supplied ketamine to numerous other clients. The “Ketamine Queen” moniker originated from her own communications and those of her customers, according to court documents.
The Perry family’s call for maximum punishment echoes victim impact statements in other high-profile drug cases, where relatives seek to emphasize the human cost beyond statistical sentencing calculations. Debbie Perry’s letter painted a picture of unrelenting sorrow that no prison term can fully alleviate, yet she argued that a strong sentence could prevent future harm.
” They won’t be back,” she wrote of lost loved ones. “That thought comes through our day everyday. There is no escape from these feelings.”
Advertisement
As the sentencing hearing proceeded Wednesday, courtroom observers anticipated emotional testimony and arguments from both sides. Sangha has remained in federal custody since her arrest. Her attorneys have not publicly commented in detail on the victim impact statement.
The broader case has raised questions about accountability in the illegal ketamine trade. While medically supervised ketamine therapy has grown in popularity for treatment-resistant depression, unregulated street supplies pose significant dangers, particularly when mixed with other substances or used by individuals with underlying health issues.
Perry’s death certificate listed the cause as “acute effects of ketamine” with contributing factors including drowning and coronary artery disease. The actor had reportedly received multiple ketamine injections in the days before his death from unauthorized sources.
Advocates for addiction recovery have used the case to call for better regulation, increased access to legitimate treatment and destigmatization of substance use disorders. Perry himself had become an advocate in his later years, supporting sober living initiatives and sharing his story to help others.
Advertisement
As Wednesday’s proceedings unfolded, the entertainment world watched closely. “Friends” co-stars and Hollywood figures have expressed continued support for the Perry family while avoiding direct commentary on the legal case.
The sentencing represents a significant milestone in the justice system’s response to Perry’s death, though it will not bring closure to the family’s grief. Debbie Perry’s statement served as a powerful reminder of the human stakes in what might otherwise be viewed as a routine drug distribution prosecution.
Federal sentencing guidelines consider factors including the quantity of drugs, the defendant’s role, criminal history and the outcome of the offense. The count tied to death carries the most severe potential penalty, elevating the case beyond standard narcotics charges.
Regardless of the exact term imposed, the Perry family has made clear their desire for a sentence that reflects the irreversible loss they attribute to Sangha’s actions. “You caused this,” Debbie Perry wrote, directing her words at the defendant.
Advertisement
As the judge weighs the arguments, the case continues to highlight the complex intersection of celebrity, addiction, illegal drug markets and federal prosecution. For the Perry family, it marks another chapter in their long journey of mourning while seeking accountability.
Matthew Perry’s legacy endures through his work, his foundation and the conversations his death has sparked about recovery and responsibility. On Wednesday, those themes converged in a Los Angeles courtroom as his stepmother’s words echoed the family’s enduring pain and demand for justice.
The recent development around the UAE stepping aside from OPEC+ coordination may have stirred headlines, but market strategist Matt Orton from Raymond James Investment believes its immediate impact on oil dynamics remains limited, even as it raises longer-term questions about the cohesion of the producer alliance.
Speaking to ET Now, Orton emphasized that the current geopolitical backdrop, particularly tensions around the Strait of Hormuz, continues to dominate oil fundamentals far more than internal OPEC politics.
UAE move: Long-term signal, limited near-term disruption On the UAE’s stance and its implications for global crude supply, Orton said: “Right now for the shorter term, it really does not mean anything because while longer term it just means more supply is likely to come online but we are not in a normal situation anymore because of the blockade of the Strait of Hormuz. So really until there is clarity with respect to what is going to happen between the US and Iran and until we start to see an easing of the blockade in the strait, there is going to be constraints for oil and there is only so much that the UAE can pump to begin with.””So, this does not come as that much of a surprise because frankly the UAE has really been trying to push more production over the past few years. They have always been upset and violated some of the curbs that they have had put in place. But if anything, it signals that there is fractures within OPEC as well. And so, it kind of questions what the future of OPEC is going to look like, what its efficacy could look like, and all of that longer term probably means that we will be well supplied in the longer term once we have a resolution and get back to some sort of normalcy, but that is going to take a lot of time,” he added.
Live Events
While acknowledging the symbolic significance of the UAE’s position, Orton suggested the real constraint on supply remains geopolitical, not institutional.Markets after a 10% rally: Selectivity becomes key With global equities already up nearly 10% from March lows, Orton cautioned that the “easy money” phase may be behind investors, even though fundamentals remain solid.“Markets have moved up at least about 10% including India at an index level, but what next really?” ET Now asked.
Orton responded: “These gains have been encouraging and I would argue that they are backed by solid fundamentals particularly in the US equity market where you have had resiliency on the overall economy and the consumer despite increased inflation and energy prices and corporate earnings have been incredibly strong. We are looking at record profit margins on the S&P 500. You are seeing smallcap earnings tick up. You have seen strong bank earnings. We are getting strong earnings from semiconductor companies, from industrials. So, the backdrop is very-very positive.”
Advertisement
However, he stressed that the next phase will be driven less by broad market beta and more by stock selection.
“The key going forward is going to be selectivity and really leaning into bifurcations that we are seeing take place,” he said.
He highlighted growing divergence across sectors:
“Because of the disruptions that have happened in the Middle East, there is going to be winners and losers with respect to those who are the energy haves and the have nots versus those who have pricing power versus those who do not have pricing power.”
Advertisement
Orton also pointed to a shift in diversification thinking:
“There is going to be increased correlation between fixed income and equities making it a little bit harder to get that traditional stock bond diversification.”
His preferred strategy: diversification within equities rather than across asset classes.
He added: “I think that means that you want to continue to lean a little bit more heavily into the AI capex beneficiary complex. I am incredibly convicted based on earnings and conversations I have had with management teams that this trade is here to stay.”
Advertisement
He also recommended selective exposure to energy and healthcare:
“Buying energy on dips makes sense especially for higher quality low leverage energy companies and then also looking to say biotechnology which is an area within healthcare that has underperformed the overall markets really from a global perspective and trying to invest in places where there is going to be more M&A activity going forward.”
Fed outlook: No major shift expected despite leadership change With an FOMC meeting underway and speculation around a leadership transition at the Federal Reserve, Orton downplayed expectations of an immediate policy pivot.
“I do not think we are going to see a policy shift. Inflation is really going to handcuff Warsh when he comes in because the economy like I have mentioned before has been incredibly resilient,” he said.
Advertisement
He added that persistent inflation limits the scope for near-term easing:
“When you have increased inflationary pressures without an end in sight with respect to what is causing those inflationary pressures, it is really hard to convince a broader committee who is already biased to hold to move towards easing.”
However, he left room for medium-term easing possibilities:
“I do think there will be potential to ease later and based on Warsh’s congressional testimony, some of the moves he will make over the medium to long term will be a little bit more dovish for the markets rather than hawkish.”
Advertisement
For markets, the key takeaway from the current Fed meeting is signalling rather than action.
“To me the meeting that we have later on today your time is going to be more signalling, seeing if Powell reiterates a lot of what he talked about during the last meeting and really get a better sense for how the broader committee is thinking about things,” Orton said.
Markets: Earnings over geopolitics—but risks remain On whether markets are now more focused on earnings than geopolitical shocks such as OPEC-related developments, Orton struck a balanced tone.
“The markets want to get past geopolitical events. I am not so sure they can fully get past geopolitical events because there is going to be continued upward pressure on oil prices until there is a resolution,” he said.
Advertisement
He noted that futures pricing already reflects prolonged uncertainty:
“When you look at back-end futures as well, they have continued to rise which really signals that there is a protracted evolution to this being baked in by the market.”
At the same time, micro-level drivers are increasingly dominant:
“Beneath the surface there was a massive move in semiconductor stocks and anything related to AI because of a story around OpenAI and questioning whether they could fulfil all of the promises that they made with respect to spending and data centre spending.”
Advertisement
Looking ahead, earnings will remain a major catalyst:
“We have 11 trillion plus dollars of market capitalisation reporting earnings results just tomorrow evening, that is going to be a significant event for the market. So, earnings are going to be in focus, but there is always the risk that no matter how good earnings are, what happens in the Middle East could derail some of that simply because of the unknown factor of just how volatile things are.”
The UAE’s surprise move to step away from OPEC+ has stirred global energy markets, raising concerns over oil supply discipline and the future stability of the producer alliance. With crude prices already sensitive to geopolitical risks, the development has added fresh uncertainty for importing nations such as India.
Speaking to ET Now, Peter McGuire, CEO, Australia-Trading.com said the decision has come at a critical moment for the market, noting, “These are early hours on this decision. We understand the significance 12% of production… it blindsided OPEC.”
He also highlighted the speed of the move, adding, “It is a quick decision… they are waiting 48 hours sort of thing,” while pointing out that “prices are up from here I would say.”
On the broader oil outlook, McGuire linked price direction to ongoing geopolitical tensions, asking, “How long is this situation going to run for?” He suggested that if tensions persist, “you are going to see prices move up from here.” Referring to current levels, he noted, “You have got WTI just on 100. I am expecting prices to continue uptick,” and further warned that “120 is going to be a… and it could be there sooner than later.”
Advertisement
On the question of whether the UAE’s exit could weaken OPEC+ cohesion, McGuire said, “It is not going to galvanise the strength of it,” adding that “it is going to put a chink in armour” and raising uncertainty over “who is going to be next.”
Live Events
He also emphasized the UAE’s strategic focus on domestic priorities, stating, “UAE to focus on national interest,” and added, “They need income and they need to ratchet that up.” He further pointed to infrastructure advantages, mentioning “the opportunity for buyers using Fujairah as a hub.” Overall, market participants remain cautious as the oil landscape adjusts to both geopolitical risks and shifting producer dynamics, with the UAE’s move adding another layer of uncertainty to an already volatile environment.
I am an independent trader and analyst specializing in the micro-cap market. My strategy combines technical analysis with the CAN SLIM method, developed by William O’Neil, to identify high-growth, underanalyzed companies. I focus on financial trends, profit growth, and institutional capital accumulation to uncover stocks with significant upside potential. In addition to equities, I have experience in Forex trading, which has helped me better understand price movements, market volatility, and sentiment-driven trends. My research approach integrates both fundamental and technical analysis, allowing me to identify strong growth stocks before they gain widespread attention. Key indicators I prioritize include relative strength, trading volume shifts, and accelerating profit growth—all of which help pinpoint stocks with the highest potential. Writing for Seeking Alpha is an integral part of my investment process, enabling me to refine my strategies, test investment theses, and engage with the investor community. In my articles, I aim to deliver in-depth company analyses, focusing on stocks with strong growth trends, improving fundamentals, and technical setups that signal potential breakouts. Through structured research, I strive to enhance market understanding and provide actionable investment insights.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Vedanta is all set to undergo its much-awaited demerger, which would see four of the Anil Agarwal-led conglomerate’s existing businesses operate as separate listed companies, with today effectively being the last date to buy Vedanta shares in order to be eligible to receive the four new shares, as the actual record date of May 1 falls on a market holiday.
In an exchange filing released on April 20, Vedanta announced that each of its eligible shareholders will get one share of Vedanta Aluminium Metal (VAML), one share of Talwandi Sabo Power (TSPL), one share of Malco Energy and one share of Vedanta Iron and Steel for every share held in Vedanta. This marks one of the biggest corporate restructurings in India’s metals and mining space, allowing shareholders to hold a direct stake in distinct sector-specific firms rather than a diversified conglomerate structure.
Vedanta demerger record date
Since May 1 is a market holiday due to Maharashtra Day, April 30 will be the effective ex-record date for the demerger. This means that shareholders who buy the company’s shares on Thursday, a day before the actual record date, will not be eligible, as shares will not be credited by the end of that trading day.
Advertisement
Hence, April 29 is likely to be the last date for interested investors to buy Vedanta shares, so that the shares are credited to their demat accounts by April 30, as per the T+1 settlement rule, making them eligible to receive shares of the four new companies emerging from the demerger.
How will Vedanta shares adjust to demerger?
Vedanta shares will undergo a special pre-open session on April 30 to discover the share price after excluding the value of the four demerged entities, which will be listed later. Post demerger, Nuvama Institutional Equities expects Vedanta to have a market capitalisation of nearly Rs 1.14 lakh crore. Notably, Vedanta currently has a market capitalisation of more than Rs 2.9 lakh crore.
Live Events
“Based on our market-cap estimates, Vedanta and Vedanta Aluminium are expected to be classified as large caps, while Vedanta Power, Vedanta Oil & Gas, and Vedanta Steel & Iron Ore fall under small cap,” it added. Vedanta shares are currently part of the Nifty Next 50 index. On the global front, it is part of the MSCI Emerging Markets Index as well as FTSE indices. Nuvama said Vedanta will continue to be part of Nifty Next 50, while the other demerged entities (Aluminium, Power, Oil & Gas, Steel) will be reflected as dummy constituents until listing. It added that Vedanta’s weight will be auto-adjusted on MSCI and FTSE indices.
When will the four new Vedanta Group companies be listed on BSE and NSE?
While the record date for the demerger has been announced, the dates when the four new companies will be listed on stock exchanges BSE and NSE have not yet been disclosed. It is important to note that the shares of Vedanta currently represent the combined value of all five companies. However, from May 1 onwards, the share price will represent the value of Vedanta excluding the four new companies.
Advertisement
Should you invest in Vedanta shares for demerger benefits?
Vedanta’s demerger is a well-structured move that should unlock shareholder value over time, said Raj Gaikar, Research Analyst at SAMCO Securities. When businesses like aluminium, zinc and oil & gas trade independently, markets tend to value them more fairly than when they are bundled together in a single conglomerate, he added.
“That said, investors considering buying ahead of the demerger should be careful, the stock has already rallied more than 25% in just the past month, meaning a part of the excitement is already reflected in the price,” Gaikar further said.
If you are a long-term investor with a 12 to 18-month horizon and comfort with commodity price swings, the analyst said this restructuring makes sense. But chasing it purely for a quick pre-demerger gain at current levels carries meaningful short-term risk.
All about Vedanta demerger
Vedanta’s long-awaited demerger plan received approval from the National Company Law Tribunal (NCLT) in December last year. When Vedanta first announced its demerger plan in 2023, it had proposed splitting its Indian operations into six separately listed companies, including a standalone base metals entity. Over time, the structure was revised. Under the approved scheme, the base metals business will remain within a restructured Vedanta, while four new listed companies will be carved out. The restructured Vedanta will continue to house the zinc and silver businesses through Hindustan Zinc and is envisaged as an incubator for future ventures. The demerger has seen significant delays, largely due to objections raised by the government.
Advertisement
Earlier last month, Vedanta Chairman Anil Agarwal told the Financial Times that the long-delayed restructuring could create “phenomenal shareholder value”. Agarwal told the FT that the new entities emerging from the conglomerate will have a free hand to grow. A privately held parent company controlled by Agarwal will retain roughly half the shareholding in each of the demerged entities, he added.
Vedanta share price
Vedanta shares have fallen more than 3% in one week, but gained over 14% in one month. The stock is up 23% in 2026 so far, after gaining 78% in one year. In the longer term, the shares of the company have rallied around 166% in three years and 204% in five years.
The company currently has a market capitalisation of more than Rs 2.90 lakh crore.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
James Entwistle – Senior Director of Investor Relations Stephan Von Schuckmann – CEO & Director Andrew Lynch – CFO & Executive VP
Advertisement
Conference Call Participants
Ryan Choi Mark Delaney – Goldman Sachs Group, Inc., Research Division Christopher Glynn – Oppenheimer & Co. Inc., Research Division Joseph Giordano – TD Cowen, Research Division Guy Drummond Hardwick – Barclays Bank PLC, Research Division Jyhhaw Liu – Evercore ISI Institutional Equities, Research Division Joseph Spak – UBS Investment Bank, Research Division Konstandinos Tasoulis – Wells Fargo Securities, LLC, Research Division Luke Junk – Robert W. Baird & Co. Incorporated, Research Division Shreyas Patil – Wolfe Research, LLC
Advertisement
Presentation
Operator
Good afternoon, everyone, and welcome to the Sensata Technologies Q1 2026 Earnings Call. [Operator Instructions] Please also note, today’s event is being recorded. I would now like to turn the conference call over to Mr. James Entwistle, Senior Director of Investor Relations. Please go ahead.
Advertisement
James Entwistle Senior Director of Investor Relations
Thank you, operator, and good afternoon, everyone. I’m James Entwistle, Senior Director of Investor Relations for Sensata, and I’d like to welcome you to Sensata’s First Quarter 2026 Earnings Conference Call. Joining me on today’s call are Stephan Von Schuckmann, Sensata’s Chief Executive Officer; and Andrew Lynch, Sensata’s Chief Financial Officer. In addition to the financial results press release we issued earlier today, we will be referencing a slide presentation during today’s conference call. A PDF of this presentation can be downloaded from Sensata’s Investor Relations website. This conference call is being recorded, and we will post a replay on our Investor Relations website shortly after the conclusion of today’s call.
As we begin, I would like to reference Sensata’s Safe Harbor statement on Slide 2. During this conference call, we will make forward-looking statements regarding future
You must be logged in to post a comment Login